Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

71 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Smoking-associated morbidities on computed tomography lung cancer screens in HIV-infected smokers.
Bommart S, Cournil A, Eymard-Duvernay S, Raffi F, Bouassida I, Le Moing V, Reynes J, Makinson A; Agence Nationale de Recherche sur le Sida et les Hépatites Virales (ANRS) HIV CHEST Study Team. Bommart S, et al. Among authors: cournil a. HIV Med. 2017 Nov;18(10):787-789. doi: 10.1111/hiv.12517. Epub 2017 May 15. HIV Med. 2017. PMID: 28503852 Free article. No abstract available.
Chest Low-Dose Computed Tomography for Early Lung Cancer Diagnosis as an Opportunity to Diagnose Vertebral Fractures in HIV-Infected Smokers, an ANRS EP48 HIV CHEST Substudy.
Thouvenin Y, Makinson A, Cournil A, Eymard-Duvernay S, Lentz P, Delemazure AS, Corneloup O, Fabre S, Quesnoy M, Poire S, Brillet PY, Cyteval C, Reynes J, Le Moing V; ANRS HIV CHEST Study Team. Thouvenin Y, et al. Among authors: cournil a. J Acquir Immune Defic Syndr. 2015 Jul 1;69(3):299-305. doi: 10.1097/QAI.0000000000000599. J Acquir Immune Defic Syndr. 2015. PMID: 26058045
Incidence of infectious morbidity events after second-line antiretroviral therapy initiation in HIV-infected adults in Yaoundé, Cameroon.
Galy A, Ciaffi L, Le Moing V, Eymard-Duvernay S, Abessolo H, Toby R, Ayangma L, Le Gac S, Mpoudi-Etame M, Koulla-Shiro S, Delaporte E, Cournil A; 2LADY Study Group. Galy A, et al. Among authors: cournil a. Antivir Ther. 2016;21(6):547-552. doi: 10.3851/IMP3030. Epub 2016 Feb 16. Antivir Ther. 2016. PMID: 26882335 Clinical Trial.
Cost-Utility Analysis of a Dolutegravir-Based Versus Low-Dose Efavirenz-Based Regimen for the Initial Treatment of HIV-Infected Patients in Cameroon (NAMSAL ANRS 12313 Trial).
Bousmah MA, Nishimwe ML, Tovar-Sanchez T, Lantche Wandji M, Mpoudi-Etame M, Maradan G, Omgba Bassega P, Varloteaux M, Montoyo A, Kouanfack C, Delaporte E, Boyer S; New Antiretroviral and Monitoring Strategies in HIV-infected Adults in Low-Income Countries (NAMSAL) ANRS 12313 Study Group. Bousmah MA, et al. Pharmacoeconomics. 2021 Mar;39(3):331-343. doi: 10.1007/s40273-020-00987-3. Epub 2020 Dec 23. Pharmacoeconomics. 2021. PMID: 33355914 Free PMC article.
APOL1 Renal Risk Variants and Kidney Function in HIV-1-Infected People From Sub-Saharan Africa.
Kabore NF, Cournil A, Poda A, Ciaffi L, Binns-Roemer E, David V, Eymard-Duvernay S, Zoungrana J, Semde A, Sawadogo AB, Koulla-Shiro S, Kouanfack C, Ngom-Gueye NF, Meda N, Winkler C, Limou S. Kabore NF, et al. Among authors: cournil a. Kidney Int Rep. 2021 Oct 16;7(3):483-493. doi: 10.1016/j.ekir.2021.10.009. eCollection 2022 Mar. Kidney Int Rep. 2021. PMID: 35257061 Free PMC article.
71 results